This was the first study to identify 5ʹ-tiRNAval as a novel tumour suppressor that acts through inhibition of FZD3/Wnt/β-Catenin signalling, which could be a potential therapeutic target in breast cancer [56]. This evidence concerns the gene FZD3 and breast carcinoma.